EAN 2016 | New approaches for developing disease modifying therapies in Alzheimer’s disease

Name: New approaches for developing disease modifying therapies in Alzheimer’s disease
Uploaded: 2016-05-29T00:00:00Z
Duration: 1 min 57 s
Description: At the 2nd Congress of the European Academy of Neurology (EAN), held in Copenhagen, Denmark, from May 28–31 2016, Jakub Hort, MD, PhD, from University in Prague, Czech Republic, reviews new approaches for the development of disease-modifying therapies, including biomarker selection approaches and improved experimental models, for the treatment of patients with Alzheimer’s disease.

Jakub Hort • 29 May 2016

EAN 2016

Alzheimer’s Disease

At the 2nd Congress of the European Academy of Neurology (EAN), held in Copenhagen, Denmark, from May 28–31 2016, Jakub Hort, MD, PhD, from University in Prague, Czech Republic, reviews new approaches for the development of disease-modifying therapies, including biomarker selection approaches and improved experimental models, for the treatment of patients with Alzheimer’s disease.